A detailed history of Tudor Financial Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Tudor Financial Inc. holds 4,025 shares of ABBV stock, worth $740,197. This represents 0.42% of its overall portfolio holdings.

Number of Shares
4,025
Previous 2,253 78.65%
Holding current value
$740,197
Previous $445 Million 60.75%
% of portfolio
0.42%
Previous 0.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$164.99 - $203.87 $292,362 - $361,257
1,772 Added 78.65%
4,025 $715 Million
Q3 2024

Nov 21, 2024

BUY
$163.84 - $199.33 $369,131 - $449,090
2,253 New
2,253 $445 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tudor Financial Inc. Portfolio

Follow Tudor Financial Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tudor Financial Inc. with notifications on news.